Mass drug administrations with dihydroartemisinin-piperaquine and single low dose primaquine to eliminate Plasmodium falciparum have only a transient impact on Plasmodium vivax: Findings from randomised controlled trials
Author:
Funder
Wellcome Trust
Bill and Melinda Gates Foundation
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference31 articles.
1. Organization WHO: World malaria report 2017. 29 November 2017.
2. Antimalarial drug resistance in Africa: key lessons for the future;S Takala-Harrison;Ann N Y Acad Sci,2015
3. The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in Southeast Asia: A cluster randomised trial;L von Seidlein;PLoS Med,2019
4. Determinants of relapse periodicity in Plasmodium vivax malaria;NJ White;Malar J,2011
5. Vivax malaria: neglected and not benign;RN Price;Am J Trop Med Hyg,2007
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Plasmodium ovale spp dhfr mutations associated with reduced susceptibility to pyrimethamine in sub-Saharan Africa: a retrospective genetic epidemiology and functional study;The Lancet Microbe;2024-07
2. Optimal Interruption of P. vivax Malaria Transmission Using Mass Drug Administration;Bulletin of Mathematical Biology;2023-04-19
3. Efficacy and safety of pyronaridine-artesunate (Pyramax®) for the treatment of uncomplicated Plasmodium vivax malaria in Northwest Ethiopia;Malaria Journal;2022-12-31
4. Clustering of malaria in households in the Greater Mekong Subregion: operational implications for reactive case detection;Malaria Journal;2021-08-26
5. Towards the elimination of Plasmodium vivax malaria: Implementing the radical cure;PLOS Medicine;2021-04-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3